Dehydroaripiprazole
CAS No. 129722-25-4
Dehydroaripiprazole ( OPC-14857; DM-14857 )
产品货号. M23455 CAS No. 129722-25-4
Dehydroaripiprazole is the active metabolite of aripiprazole. Aripiprazole is an antipsychotic drug, which is metabolized by CYP3A4 and CYP2D6 and mainly forms dehydroaripiprazole.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥583 | 有现货 |
|
10MG | ¥988 | 有现货 |
|
25MG | ¥2001 | 有现货 |
|
50MG | ¥2981 | 有现货 |
|
100MG | ¥4398 | 有现货 |
|
500MG | ¥9396 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Dehydroaripiprazole
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Dehydroaripiprazole is the active metabolite of aripiprazole. Aripiprazole is an antipsychotic drug, which is metabolized by CYP3A4 and CYP2D6 and mainly forms dehydroaripiprazole.
-
产品描述Dehydroaripiprazole is the active metabolite of aripiprazole. Aripiprazole is an antipsychotic drug, which is metabolized by CYP3A4 and CYP2D6 and mainly forms dehydroaripiprazole. Dehydroaripiprazole has antipsychotic activity equivalent to aripiprazole.
-
同义词OPC-14857; DM-14857
-
通路Endocrinology/Hormones
-
靶点5-HT Receptor
-
受体5-HT1A
-
研究领域——
-
适应症——
化学信息
-
CAS Number129722-25-4
-
分子量446.4
-
分子式C23H25Cl2N3O2
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESO=C1NC2=C(C=CC(OCCCCN3CCN(C4=CC=CC(Cl)=C4Cl)CC3)=C2)C=C1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Kirschbaum KM, et al. Serum levels of aripiprazole and dehydroaripiprazole, clinical response and side effects. World J Biol Psychiatry. 2008;9(3):212-8.
产品手册
关联产品
-
Peptide 401
Peptide 401 is an antimicrobial peptide (AMP) derived from the venom of bees and wasps. Peptide 401 induces mast cell degranulation, activating histamine release from peritoneal mast cells. Additionally, peptide 401 exhibits some anti-inflammatory activity, decreasing paw edema in animal models.
-
AVN-101
A higly potent, orally bioavailable, BBB permeable 5-HT7 receptor antagonist with Ki of 153 pM, with slightly lesser potency toward 5-HT6, 5-HT2A and 5HT-2C (Ki=1.2-2.0 nM).
-
NAN-190 hydrobromide
NAN-190 is a 5-HT1A receptor antagonist with Ki of 0.6 nM; also potently blocks the α2-adrenergic receptor.